Jpmorgan Chase & CO Stoke Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 20,257 shares of STOK stock, worth $614,597. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,257

Previous 19,964 1.47%

Holding current value

$614,597

Previous $220,000 39.09%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$6.65 - $12.74 $1,948 - $3,732	293 Added 1.47%	20,257 $134,000
Q4 2024 Feb 12, 2025	BUY	$10.8 - $13.92 $48,729 - $62,807	4,512 Added 29.2%	19,964 $220,000
Q3 2024 Dec 26, 2024	BUY	$12.24 - $15.92 $2,435 - $3,168	199 Added 1.3%	15,452 $189,000
Q3 2024 Nov 08, 2024	BUY	$12.24 - $15.92 $2,435 - $3,168	199 Added 1.3%	15,452 $189,000
Q2 2024 Dec 26, 2024	SELL	$11.03 - $17.52 $2,194 - $3,486	-199 Reduced 1.29%	15,253 $206,000
Q2 2024 Aug 12, 2024	BUY	$11.03 - $17.52 $47,528 - $75,493	4,309 Added 39.37%	15,253 $206,000
Q1 2024 Dec 26, 2024	SELL	$4.12 - $14.17 $18,572 - $63,878	-4,508 Reduced 29.17%	10,944 $147,000
Q1 2024 May 10, 2024	SELL	$4.12 - $14.17 $29,618 - $101,868	-7,189 Reduced 39.65%	10,944 $147,000
Q4 2023 Dec 26, 2024	BUY	$3.37 - $5.4 $9,034 - $14,477	2,681 Added 17.35%	18,133 $95,000
Q4 2023 Feb 12, 2024	SELL	$3.37 - $5.4 $28,297 - $45,343	-8,397 Reduced 31.65%	18,133 $95,000
Q3 2023 Nov 14, 2023	BUY	$3.78 - $11.99 $12,712 - $40,322	3,363 Added 14.52%	26,530 $104,000
Q2 2023 Aug 11, 2023	SELL	$7.93 - $13.82 $724,009 - $1.26 Million	-91,300 Reduced 79.76%	23,167 $246,000
Q1 2023 May 18, 2023	BUY	$7.65 - $10.38 $215,271 - $292,093	28,140 Added 32.6%	114,467 $953,000
Q1 2023 May 11, 2023	BUY	$7.65 - $10.38 $477,880 - $648,417	62,468 Added 261.82%	86,327 $719,000
Q4 2022 Feb 13, 2023	BUY	$7.07 - $15.69 $2,057 - $4,565	291 Added 1.23%	23,859 $220,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $13,439 - $24,107	1,070 Added 4.76%	23,568 $302,000
Q2 2022 Aug 11, 2022	BUY	$10.36 - $23.93 $29,940 - $69,157	2,890 Added 14.74%	22,498 $297,000
Q1 2022 May 11, 2022	BUY	$17.19 - $26.1 $57,999 - $88,061	3,374 Added 20.78%	19,608 $412,000
Q4 2021 Feb 10, 2022	BUY	$18.11 - $30.72 $27,273 - $46,264	1,506 Added 10.23%	16,234 $390,000
Q3 2021 Nov 12, 2021	BUY	$23.65 - $34.44 $348,317 - $507,232	14,728 New	14,728 $375,000

Others Institutions Holding STOK

# of Institutions

138

Shares Held

58M

Call Options Held

2.7K

Put Options Held

57.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $1.2B
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Stoke Therapeutics, Inc. Transaction History